Investors Asset Management of Georgia’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-2	Closed	–	–	368
2022 Q3	$0	Hold	2	–	–	﹤0.01%	637
2022 Q2	$0	Buy	+2	New	–	﹤0.01%	589